Be wary of lithium ‘gossip’: IGO
Pessimism is seeping into lithium. But IGO boss Ivan Vella says be careful not to believe everything you hear.
News
Slice of budget surplus to spur REE projects: Godolphin
Godolphin’s Jeneta Owens says extra Federal backing will entice private investment into rare earths projects.
Qld could address gas shortfall
Queensland could help answer the expected gas supply shortfall on Australia’s east coast.
Nickel and manganese losers in EV shift
BloombergNEF has made big adjustments to its battery metals forecasts as cheaper EV technology emerges.
IMM sinks despite cancer treatment trial success
A trial of Immutep’s treatment for head and neck cancer produced positive results. Yet investors punished IMM, driving down its share price by 35 per cent.
Top 10 at 11: Fresh from the ASX today
Good morning, and welcome to Stockhead’s Top 10 at 11-ish, a short, sharp update to help frame the trading day.
Amazon hits $2T; property market bullish next year
Amazon reaches US$2 trillion market cap for the very first time, and will the Aussie property market remain strong in 2024?
ASX juniors pump on rare earths and copper
Yeehaw! America’s Cowboy State is backing an Aussie rare earths hopeful with a $10.7m grant.
ASX non-bank lenders: Future of Aussie finance?
Non-bank lenders surge in Australia’s credit market, filling gaps left by traditional banks.
It’s raining gold in West Africa for Many Peaks Minerals
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing another gold acquisition from Many Peaks Minerals.
Don’t let tech run stop you looking beyond Wall Street
Wall Street’s Magnificent Seven have dominated global gains. But Franklin Templeton suggests gains could be found elsewhere going forward.
Here’s why vanadium is heating up
Vanadium is the other battery metal and demand could increase as VRFBs hit the mainstream.
Aussie home sales hit 15-year profit highs
The profitability of flogging your Aussie home has hit an almost 15-year high, according to CoreLogic data.
Morgans’ ASX tech picks earning, not burning cash
Stockbroker Morgans says these three ASX tech stocks stand out for being cash earners rather than burners with funds for future growth.
Sticky CPI pulls pants off ASX as August rate hike looms
Not a great day for local markets or mortgage holders. The May CPI read shows inflation remains heated if not hot and markets fell sharply on the news.
Cleo on track for FDA approval of ovarian test
ASX health stock Cleo Diagnostics now has a clearer path to US approval for its blood test to detect ovarian cancer, thanks to FDA advice.
Nvidia rebounds; EV maker Rivian up 53pc
Nvidia rebounds with a +6.75pc surge after recent declines, while Novo Nordisk doubles down on Wegovy and Ozempic.
FDA joy here or near for these ASX biotechs
FDA approval can be a superpower for an ASX biotech, opening doors to big profits. These stocks have gained it this year, or are close.
Rise and Shine: Everything you need to know before the ASX opens
Good morning, and Happy Wednesday! Here’s everything you need to know before the ASX opens today.
ASX Small Caps Lunch Wrap: Who’s been busted playing dress-ups in the US this week?
After a rough start to the week local markets opened higher on Tuesday with every sector enjoying some time in the sunshine, despite a lull among tech stocks led by market volatility in that sector.
Free Whelan: It’s crowded inside The Magnificent 7
James Whelan notes there’s a growing pile of fundies invested in the “The Mag 7” who believe the trade is both overcrowded and required.
Tech firms must earn during high rates: Morgans
Stockbroker Morgans says ongoing high interest rates mean tech companies must be cash earners and not burners.
The ASX surged on Tuesday, with all sectors in the green
The local benchmark had its best day in almost two months after a mixed lead overnight on Wall Street.
Corella Resources: Bringing some star power to industrial markets with kaolin and silica
Corella Resources’ CEO Jess Maddren joins Sarah Hughan on Stockhead TV to talk about kaolin and silica.
Helix extends its Cobar copper-gold hunt
Helix Resources is a standout ressie gainer today on copper-gold news. MTM has also made a pretty flash reveal.
Break it Down: VMM stands tall with Colossus maiden rare earths resource
Stockhead’s Sarah Hughan talks on the release of VMM’s maiden resource posted at its Colossus project in Brazil.
Break it Down: QMines has new copper-gold targets in Artillery Road
Break it Down host Sarah Hughan dissects the new copper-gold targets at QMines’ Mt Chalmers project.
Equinox Resources placing itself in pole position in the Pilbara
Stockhead’s Fraser Palamara dives into Equinox Resources’ (ASX:EQN) and its latest MRE release for direct shipping ore at the company’s Hamersley iron ore project in the Pilbara.
Break it Down: Firetail Resources announces new project
Break it Down host Fraser Palamara dissects Firetail Resources’ binding deal to acquire 80% of the York Harbour project.
Break it Down: New World Resources bolsters drilling
In this episode of Break it Down, host Fraser Palamara explains why New World Resources has upped its drilling in Arizona, USA.
Break it Down: LTR Pharma flexes on SPONTAN success
In this episode of Break it Down, host Fraser Palamara discusses important new study results for LTR Pharma’s SPONTAN nasal spray.
Break it Down: Spartan Resources flexes on gold
Break it down host Sarah Hughan discusses the exceptional gold intercepts shared to the market today from Spartan Resources.
Break it Down: Aura Energy flexes uranium resource upgrade
Break it Down host Sarah Hughan explains the mega resource upgrade out of Aura Energy’s Tiris uranium project in Mauritania, Africa
Break it Down: Strickland Metals strikes gold in Serbia
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing fresh gold results from Strickland Metals.
Break it Down: Why Dante could be a trailblazer
Terra Metals is excited by new drilling results from its Dante project in Western Australia’s West Musgrave region.
Break it Down: Imricor trial has a heartbeat
Break it down host Fraser Palamara talks the early success Imricor Medical Systems has seen in its trial in search of FDA approval.
Pursuit Minerals on a roll at Rio with substantial high-grade lithium
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing high-grade lithium from Pursuit Minerals.
Gene test that spotlights disease risk
A pioneering gene test has returned stunning results, with nearly 80 per cent of those studied showing elevated risk for at least one serious disease.
Top 10 at 11ish: Who is flagged further positive results?
Helix Resources has flagged further positive results in its search for new copper-gold deposits from the auger geochemical sampling program in the Eastern Group tenements in NSW.
Rise and Shine: Everything you need to know before the ASX opens
Tim “Not a Doctor” Boreham delves into the paediatric pot-stock Neurotech, the sadly Freo-supporting Jess Cummins looks at micro-caps with major support, and the delightfully hamster-cheeked Christian Edwards has caught up with James Whelan.
Dr Boreham’s Crucible: Can this paediatrics biotech reach its pot–ential?
Is Neurotech ‘the next Neuren’? One thing’s for sure, it’s kicking more goals than your standard ‘pot stock’.
We now have a Bitcoin ETF, but how ESG is BTC?
Is the VanEck Bitcoin ETF worth a look for Aussie investors? We evaluate through an ESG lens.
Taylor Collison bullish on Reckon’s legal strategy
Taylor Collison gives accounting-software solutions firm Reckon an ‘Outperform’ rating.
Meteoric’s Caldeira is a rare earths unicorn
The scale and grade of Meteoric’s Caldeira project makes it stand out from other ionic adsorption clay-hosted REE projects.
Why Renegade is partnered with this mega miner
Here, Stockhead digs into the JV partnership IOCG-hunting microcap has with copper-producing titan Glencore.
ASX miners go missing again on Monday
Local markets started Monday with wins for Myer and losses for almost all other headline acts.
Encounter strengthens niobium find; Burley muscles up
ENR is the strongest-looking ASX ressie stock so far today, with a niobium-news-based +60% gain.
Pilbara still a buy: Jarden
Analysts at Jarden say lithium miner Pilbara Minerals is still a buy, despite dialling down medium term prices.
Everything you need to know before the ASX opens
Morning and Happy Monday! Here’s everything (well, some) of what you need to know before the ASX opens.
ASX Small Caps Lunch Wrap: Inflation, AI angst lead ASX lower on Monday morning
Myer stock has surged on Monday morning after news of a potential merger with Solomon Lew’s Apparel Brands – which boasts a portfolio of plucky fashion retailers like Portmans, Dotti, Just Jeans and Jay Jays. The ASX is lower at lunch.
Proteomics to sell in France, Recce trials to begin
Proteomics to start selling in France, Recce granted ethical approval for clinical trials, and EMV gets $1.25m grant.
Time to take stock of potential EOFY discards?
It’s tax time again. Will you be cashing in any chips before June 30?
AvonWest logistics hub could address Perth’s road freight woes
The AvonWest logistics and enterprise hub in Northam could improve Perth’s road freight security and potentially build up a buffer against unexpected disruptions.
Top 10 at 10: This niobium explorer is today’s Crean of the crop
Encounter Resources (ASX:ENR) drills into thick, high grade niobium in WA’s red-hot West Arunta region.
Calming ASX stocks offer anxiety relief – Part 2
With mental health issues on the increase in Australia, these ASX wellness stocks have stepped up to help.
Fears how a post-IPO Guzman y Gomez will come out
Tough truths ahead for Guzman y Gomez investors. Yes it has a presence in the States – but so does Mexico.
Nvidia loses top spot to Microsoft on ‘Triple Witching’ day
ASX 200 to open lower on Monday. Nvidia lost -3pc, relinquishing top market cap spot to Microsoft. Australian CPI due on Wednesday.
How to find ASX stocks with positive sentiment
How do you read market mood on the ASX? The Put/Call Ratio is one tried and tested way.
The week ahead on the ASX
Aussie investors will be keen to catch any related sentiment they can glean ahead of May’s CPI inflation read.
Gold: French bank SocGen bullish as precious yellow metal rises
Gold ends the week on the rise. French bank Société Générale is still following la route de briques jaune.
Power Up: We need to have a talk about nuclear energy
The Coalition has unveiled some details about its nuclear policy, but a deep dive shows that it does little to build a case for building our own reactors.
ASX Small Caps Lunch Wrap: Has anyone noticed something’s up with the water this week?
Local markets were flat this morning, Wall Street had the night off and it looks like Mexican food’s definitely on the ASX menu for lunch.
Resources Top 4: Terra Metals double bags it on copper-PGE discovery
Terra Metals is well up after finding ‘Bushveld style’ copper-PGE reefs at its Dante project in WA.
ASX Small Caps and IPO Weekly Wrap: 21 Jun, 2024
The ASX 200 gained slightly, Schrole Group went nuts and Guzman y Gomez is worth $3 billion. What a week!
ASX Small Caps Lunch Wrap: Whose AI turned the drive-thru into a bun fight this week?
Local markets rose, then fell, and then rose again on an otherwise pretty boring Friday morning for the ASX.
Top 10 at 10: These ASX stocks are flying and faceplanting on Friday
The best (and worst) performing ASX stocks in early trade using live data.
Ten Bagger: The ‘triple whammy’ hitting small mining stocks
AI darling Nvidia’s rise as the world’s largest company is a surprising indicator of the headwinds facing small resources stocks.
ASX health stocks providing calm and anxiety relief – part 1
While many Australians are turning to doctors and other health professionals to assist with their mental health and stress management, the ASX wellness sector is also increasingly looking to provide support.
Biotron jumps 15pc after hitting primary objectives of Phase 2 trial
Biotron (ASX:BIT) jumped +15% this morning after announcing promising results from its BIT225-011 Phase 2 clinical trial.
Time ticks for iron ore mine despite ‘very strong’ demand
Mineral Resources insists demand for the low-grade iron ore it produces remains strong despite announcing it will place an historic mine on ice.
Felix Gold’s fantastic Fairbanks maiden resource
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the maiden mineral resource estimate from Felix Gold.
Can BlinkLab’s autism diagnosis tool replicate the huge success of ResApp?
BlinkLab’s app diagnoses autism early through blink reflex analysis. The company is co-founded and chaired by ResApp founder, Brian Leedman.
Broker downgrades The Reject Shop, but still gives it a big price target
Jarden Research downgrades The Reject Shop (ASX: TRS) but despite facing challenges, TRS remains undervalued, says Jarden.
Market Highlights: Guzman, VanEck Bitcoin ETF to make ASX debut
Guzman y Gomez debuts on ASX with $22 share price. Australia’s first ever Spot Bitcoin ETF will also debut today.
Control Bionics surges over 50pc after TGA approval of DROVE wheelchair
Control Bionics’ shares surge after TGA approval, and Botanix Pharma granted US FDA approval for Sofdra (sofpironium) gel.
Top 10 at 10: High tech wheelchairs, copper discoveries, and a big uranium bounty
Control Bionics (ASX:CBL) can now sell its autonomous wheelchair module, DROVE, in Australia.
Takeovers Panel holds fire on Rio uranium complaint
Steven Spielberg’s Minority Report is all about cops who can see the future. This Rio Tinto minority holder wants the Takeovers Panel to do the same thing as the mining giant eyes local uranium digger ERA.
ASX edges lower, but uranium miners rally on Dutton’s nuclear plants pledge
ASX closes lower, despite Energy sector strength, led by uranium mining stocks which surged after the release of opposition leader Peter Dutton’s nuclear energy plans.
London-listed Chilean lithium developer chases second home on ASX
London-listed CleanTech Lithium is seeking a home away from home on the ASX in the hope of developing an innovative Chilean brine project.
India is the new China as stocks rocket and share market value tops $US5trn
Led by gains in IT and financial stocks, India’s benchmark indices ended at record highs for a third straight session on Tuesday, with the total valueof Indian equities now topping $US5trn for the first time.
Original URL: https://www.news.com.au/finance/business/stockhead/news/page/65